Skip to main content

eHealth, Inc. (EHTH) Stock Forecast

Data as of May 2, 2026

Financial Services · Current price $2.06 (-0.24%)

Consensus Target
$9.00
Upside
+46.0%
Analysts
3
Rating
Hold(3.00)

Price Target Range

Low $9.00High $9.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Hold
Strong Buy0
Buy0
Hold2
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Nov 25, 2025Ben HendrixRBC Capital$9.00+338.0%
Nov 6, 2024George SuttonCraig-Hallum$7.00+240.6%
Aug 14, 2024George HillDeutsche Bank$2.00-2.7%
Dec 1, 2022George SuttonCraig-Hallum$6.00+192.0%

EHTH vs Sector & Market

MetricEHTHFinancial Services AvgLarge Cap Avg
Analyst Rating3.002.512.41
Analyst Count3818
Target Upside+46.0%+64.8%+14.9%
P/E Ratio1.47-5.0031.19

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$421M$428M$434M4
2027-12-31$438M$452M$465M4
2028-12-31$488M$488M$488M1
2029-12-31$649M$665M$685M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$0.74$0.77$0.803
2027-12-31$1.02$1.06$1.103
2028-12-31$0.83$0.86$0.891
2029-12-31$1.92$1.98$2.061

Frequently Asked Questions

What is the analyst consensus for EHTH?

The consensus among 3 analysts covering eHealth, Inc. (EHTH) is Hold with an average price target of $9.00.

What is the highest price target for EHTH?

The highest price target for EHTH is $9.00, set by Ben Hendrix at RBC Capital on 2025-11-25.

What is the lowest price target for EHTH?

The lowest price target for EHTH is $2.00, set by George Hill at Deutsche Bank on 2024-08-14.

How many analysts cover EHTH?

3 analysts have issued ratings for eHealth, Inc. in the past 12 months.

Is EHTH a buy or sell right now?

Based on 3 analyst ratings, EHTH has a consensus rating of Hold (3.00/5) with a +46.0% upside to the consensus target of $9.00.

What are the earnings estimates for EHTH?

Analysts estimate EHTH will report EPS of $0.77 for the period ending 2026-12-31, with revenue estimated at $428M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.